Rasio utang jangka dawa marang modal mustangbio.com (MBIO)

Simbol lan logo merek Mustang Bio Inc (MBIO)

The long-term debt-to-equity structure of Mustang Bio, Inc. (MBIO) reflects a dependence on the complexity of individualized CAR-T therapy production. The 0.00 mark serves as a key metric capturing the financial leverage. Stability of these indicators relies on rigorous cryo-logistics for biomaterials. However, a deficit of R&D funding and strict FDA regulations regarding genome editing limit the expansion of the client base.

mustangbio.com (MBIO): Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 31.10.2026
Barang utama mustangbio.com

This indicator determines the ratio of long-term borrowings to equity, measuring the degree of the business's financial autonomy. By analyzing the long-term financial leverage ratio, an investor distinguishes a sustainable reduction in debt load from short-term liquidity fluctuations. The current calculated value of the metric is 0.00. Minimizing borrowed capital reduces default risks, which allows Mustang Bio, Inc. (MBIO) to focus on retaining scarce R&D specialists through stock option programs.

Pesaing wigati

Rasio utang jangka dawa marang modal TEM (Tempus)|Utang jangka dawa marang ekuitas Qiagen Group (QGEN)|Isis Pharmaceuticals - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal RGEN (Repligen Corporation)|Utang jangka dawa marang modal aviditybiosciences.com RNA|CRSP - Utang jangka dawa marang ekuitas|GeneDx Holdings (WGS) - Rasio utang jangka dawa marang ekuitas|RARE (Ultragenyx Pharma) - Rasio utang jangka dawa marang ekuitas|Beam Tx (BEAM) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Sarepta Therapeutics, Inc.|twistbioscience.com (TWST) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas TXG (10x Genomics)|Rasio silihan jangka dawa marang modal NTLA|Utang jangka dawa marang modal STOK (Stoke)|Utang jangka dawa marang modal BioLife BLFS|WVE - Utang jangka dawa marang ekuitas|MAZE (mazetx.com) - Rasio utang jangka dawa marang modal|SION: Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Prime Medicine Inc PRME|Rasio utang jangka dawa marang ekuitas TSHA|QURE: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal MGTX|Utang jangka dawa marang ekuitas RGNX (regenxbio.com)|Utang jangka dawa marang modal SLDB (Solid Biosciences)|Rasio tanggungan utang jangka dawa marang modal Ocugen Inc (OCGN)|PACB - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Benitec Corp|DSGN (Design Therapeutics) - Rasio utang jangka dawa marang ekuitas|rocketpharma.com - Koefisien utang jangka dawa marang modal|FDMT (4D Molecular Therapeutics, Inc.) - Utang jangka dawa marang modal|Lexeo (LXEO) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Korro Bio, Inc. (KRRO)|Editas Corp - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal SLN (Silence Therapeutics)|PRQR - Rasio utang jangka dawa marang ekuitas|CDXS: Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Sangamo Therapeutics Inc. SGMO|nautilus.bio (NAUT) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Metagenomi Therapeutics|DTIL (Precision BioSciences) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas GBIO|Utang jangka dawa marang modal BOLD|Rasio tanggungan utang jangka dawa marang modal exicuretx.com|Utang jangka dawa marang ekuitas Imunon IMNN|Phio Pharmaceuticals Corp (PHIO) - Kewajiban jangka dawa marang modal|TransCode - Utang jangka dawa marang modal|BNGO (Bionano Genomics, Inc.) - Rasio utang jangka dawa marang modal|Applied DNA Sciences, Inc. (APDN) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal BLUE|IPA (ImmunoPrecise Antibodies Ltd) - Utang jangka dawa marang modal|Utang jangka dawa marang modal Omega Therapeutics Corp|Utang jangka dawa marang ekuitas Singular Genomics Systems (OMIC)|Rasio utang jangka dawa marang ekuitas regulusrx.com RGLS|Syros Pharmaceuticals, Inc. - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal Telesis Bio Inc. TBIO|TCON - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Unity Biotechnology, Inc UBX